Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Latest Indonesian free meal poisoning outbreaks affect 800, lawmaker says
1+ hour, 32+ min ago (305+ words) JAKARTA, Sept 3 (Reuters) – Nearly 800 Indonesians have fallen ill in separate incidents of food poisoning linked to the government’s free meals programme, a member of a parliamentary commission overseeing health said, including more than 500 students in East Java province this week....
Australia’s Regis Healthcare slumps as aged-care funding raise falls short of cost pressures
2+ hour, 1+ min ago (219+ words) Sept 3 (Reuters) – Shares of Australia’s Regis Healthcare plunged nearly 35% on Thursday after the company said an increase in the government’s funding rate for residential aged care fell well short of inflation across the sector and economy. • The Department of Health,…...
From hunger to obesity: Developing world faces growing threat to child health
6+ hour, 23+ min ago (1665+ words) By Jennifer Rigby, Ajeng Ulfiana, Stanley Widianto and Heru Asprihanto BOGOR, Indonesia, Sept 3 (Reuters) – Intan Permatasari’s mother simply couldn’t refuse her daughter’s pleas for food. By the time she was 4, Intan had outgrown all the kindergarten uniforms and had to…...
US Pentagon issues clinical guidelines on troop testosterone screening to start immediately
7+ hour, 43+ min ago (264+ words) Sept 2 (Reuters) – The U.S. Pentagon issued detailed guidance on Wednesday for a new, mandatory testosterone deficiency screening policy for active-duty and reserve service members age 30 and older, a follow-up to Defense Secretary Pete Hegseth’s July announcement. The guidance, which is…...
Ultragenyx’s rare disease drug fails in late-stage trial; shares plunge
9+ hour, 18+ min ago (135+ words) Sept 2 (Reuters) – Ultragenyx Pharmaceutical said on Wednesday its experimental drug for a rare genetic neurodevelopmental disorder did not meet the main goal in a late-stage trial, sending its shares down 40% in aftermarket trading. The drug, apazunersen, was tested as a…...
WHO’s Tedros says Ebola response must be scaled up to tackle Congo outbreak
15+ hour, 24+ min ago (284+ words) GENEVA, Sept 2 (Reuters) – The head of the World Health Organization on Wednesday said the Ebola response needs to be scaled up in order to tackle the outbreak in the Democratic Republic of Congo, with tracking the chains of transmission still…...
Altria sues FDA over tobacco product review system
15+ hour, 17+ min ago (439+ words) By Emma Rumney and Jonathan Stempel LONDON/NEW YORK, Sept 2 (Reuters) – Marlboro-maker Altria on Wednesday sued the U.S. Food and Drug Administration, seeking to force the agency to overhaul a product review process that tobacco companies say has stifled their…...
As schools re-open, Congo drops remote learning plan in Ebola red zone
15+ hour, 57+ min ago (498+ words) By Gradel Muyisa and Ange Kasongo BENI, Democratic Republic of Congo, Sept 2 (Reuters) – Schools reopened this week in areas of Democratic Republic of Congo hardest hit by Ebola, after authorities decided the risk of transmission was outweighed by the risk…...
uniQure seeks US approval for Huntington’s gene therapy after FDA reversal
17+ hour, 13+ min ago (336+ words) Sept 2 (Reuters) – Dutch gene therapy developer uniQure said on Wednesday it had applied for U.S. approval of its experimental treatment for Huntington’s disease after the FDA reversed its earlier position on the drug, sending the company’s shares up 5% in premarket…...
Teva’s immune disorder drug meets main goal in mid-stage trial
16+ hour, 59+ min ago (261+ words) Sept 2 (Reuters) – Israeli drugmaker Teva Pharmaceutical Industries said on Wednesday its experimental drug helped prevent gluten-related intestinal damage in adults with celiac disease, meeting the main goal of a mid-stage trial. U.S.-listed shares of the company were up over…...